Cytotoxic Lanostanoids from Poria cocos

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Poria cocos is a traditional medicinal mushroom known for its diverse bioactive compounds.
• Lanostanoids are a class of triterpenes with a wide range of biological activities, including anticancer properties.
• Understanding the chemical diversity and bioactivity of lanostanoids from P. cocos can lead to the development of new therapeutic agents.

Purpose of the Study:

• To isolate and characterize new and known lanostanoids from the sclerotia of Poria cocos.
• To evaluate the antiproliferative activity of the isolated compounds against human leukemia cell lines.
• To investigate potential molecular targets responsible for the observed antiproliferative effects.

Main Methods:

• Isolation of lanostanoids from Poria cocos using chromatographic techniques.
• Structure elucidation of new compounds through extensive spectroscopic analyses (NMR, MS).
• Determination of absolute configuration using Mosher's method.
• In vitro antiproliferative assays against Molt 4, CCRF-CEM, HL 60, and K562 leukemia cell lines.
• Computational analysis using Chemical Global Positioning System for Natural Products (ChemGPS-NP).

Main Results:

• Six new lanostanoids (1-6) and 16 known lanostanoids were successfully isolated and characterized.
• Dehydropachymic acid (9), dehydroeburicoic acid (12), pachymic acid (14), and lanosta-7,9(11),24-trien-21-oic acid (20) demonstrated significant antiproliferative activity against CCRF-CEM cells.
• Compounds 9 and 12 also showed notable antiproliferative effects against Molt 4 and HL 60 cell lines.
• Computational analysis suggested that targets other than topoisomerases may be involved in the observed activity.

Conclusions:

• Poria cocos is a rich source of structurally diverse lanostanoids with potent antiproliferative activities.
• Specific lanostanoids, such as dehydropachymic acid and dehydroeburicoic acid, show promising activity against leukemia cell lines.
• The findings suggest potential for developing novel anticancer agents from P. cocos, with mechanisms potentially distinct from topoisomerase inhibition.